Clinical Trial Update: Photodynamic Therapy-Induced Immune Modulation: Part III [Phase 1]

View source ↗

Summary

Phase 1 trial investigating photodynamic therapy-induced immune modulation for actinic keratosis was terminated, with results posted in December 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Snippet

Sponsor: Wright State University | Conditions: Actinic Keratosis, Photodynamic Therapy | Phase 1 | Status: TERMINATED | Results posted: 2024-12-19